Reply to Gohar on ‘Lungs, methotrexate and psoriasis’, a comment on ‘Fatal, incidental, idiopathic pulmonary fibrosis in a patient receiving long-term low-dose methotrexate for psoriasis’

A. Affleck; A. Goudie; R. Smith

doi:10.1111/ced.13994

Reply to Gohar on ‘Lungs, methotrexate and psoriasis’, a comment on ‘Fatal, incidental, idiopathic pulmonary fibrosis in a patient receiving long-term low-dose methotrexate for psoriasis’

A. Affleck (Lead / Corresponding author), A. Goudie, R. Smith

Research output: Contribution to journal › Letter › peer-review

2 Citations (Scopus)

132 Downloads (Pure)

Abstract

There may be a group of patients with psoriasis who are at increased risk of developing interstitial lung disease and identifying these individuals is desirable. However, at the present time we do not believe that routine screening with chest CT scanning is indicated nor any proposed preventative medical treatments both of which may have side-effects.

Original language	English
Pages (from-to)	595
Number of pages	1
Journal	Clinical and Experimental Dermatology
Volume	44
Issue number	5
Early online date	25 Apr 2019
DOIs	https://doi.org/10.1111/ced.13994
Publication status	Published - 1 Jul 2019

Keywords

Humans
Idiopathic Pulmonary Fibrosis
Lung
Methotrexate
Psoriasis

ASJC Scopus subject areas

Dermatology

Access to Document

10.1111/ced.13994

Author Accepted ManuscriptAccepted author manuscript, 138 KB

Cite this

@article{5d346aa1e0ea4d30a7cd058ee530e6f2,

title = "Reply to Gohar on {\textquoteleft}Lungs, methotrexate and psoriasis{\textquoteright}, a comment on {\textquoteleft}Fatal, incidental, idiopathic pulmonary fibrosis in a patient receiving long-term low-dose methotrexate for psoriasis{\textquoteright}",

abstract = "There may be a group of patients with psoriasis who are at increased risk of developing interstitial lung disease and identifying these individuals is desirable. However, at the present time we do not believe that routine screening with chest CT scanning is indicated nor any proposed preventative medical treatments both of which may have side-effects. ",

keywords = "Humans, Idiopathic Pulmonary Fibrosis, Lung, Methotrexate, Psoriasis",

author = "A. Affleck and A. Goudie and R. Smith",

year = "2019",

month = jul,

day = "1",

doi = "10.1111/ced.13994",

language = "English",

volume = "44",

pages = "595",

journal = "Clinical and Experimental Dermatology",

issn = "0307-6938",

publisher = "Oxford University Press",

number = "5",

}

Reply to Gohar on ‘Lungs, methotrexate and psoriasis’, a comment on ‘Fatal, incidental, idiopathic pulmonary fibrosis in a patient receiving long-term low-dose methotrexate for psoriasis’. / Affleck, A. (Lead / Corresponding author); Goudie, A.; Smith, R.
In: Clinical and Experimental Dermatology, Vol. 44, No. 5, 01.07.2019, p. 595.

Research output: Contribution to journal › Letter › peer-review

TY - JOUR

T1 - Reply to Gohar on ‘Lungs, methotrexate and psoriasis’, a comment on ‘Fatal, incidental, idiopathic pulmonary fibrosis in a patient receiving long-term low-dose methotrexate for psoriasis’

AU - Affleck, A.

AU - Goudie, A.

AU - Smith, R.

PY - 2019/7/1

Y1 - 2019/7/1

N2 - There may be a group of patients with psoriasis who are at increased risk of developing interstitial lung disease and identifying these individuals is desirable. However, at the present time we do not believe that routine screening with chest CT scanning is indicated nor any proposed preventative medical treatments both of which may have side-effects.

AB - There may be a group of patients with psoriasis who are at increased risk of developing interstitial lung disease and identifying these individuals is desirable. However, at the present time we do not believe that routine screening with chest CT scanning is indicated nor any proposed preventative medical treatments both of which may have side-effects.

KW - Humans

KW - Idiopathic Pulmonary Fibrosis

KW - Lung

KW - Methotrexate

KW - Psoriasis

UR - http://www.scopus.com/inward/record.url?scp=85066018276&partnerID=8YFLogxK

U2 - 10.1111/ced.13994

DO - 10.1111/ced.13994

M3 - Letter

C2 - 31022304

SN - 0307-6938

VL - 44

SP - 595

JO - Clinical and Experimental Dermatology

JF - Clinical and Experimental Dermatology

IS - 5

ER -

Reply to Gohar on ‘Lungs, methotrexate and psoriasis’, a comment on ‘Fatal, incidental, idiopathic pulmonary fibrosis in a patient receiving long-term low-dose methotrexate for psoriasis’

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this